Orthometrix Valuation
| OMRX Stock | USD 0.0001 0.00 0.00% |
Orthometrix seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Orthometrix from analyzing the company fundamentals such as Return On Asset of -0.46, current valuation of 74.46 K, and Gross Profit of 591.05 K as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Orthometrix's price fluctuation is very steady at this time. Calculation of the real value of Orthometrix is based on 3 months time horizon. Increasing Orthometrix's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Orthometrix is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Orthometrix Stock. However, Orthometrix's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Orthometrix's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Orthometrix's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Orthometrix helps investors to forecast how Orthometrix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Orthometrix more accurately as focusing exclusively on Orthometrix's fundamentals will not take into account other important factors: Orthometrix Total Value Analysis
Orthometrix is now projected to have valuation of 74.46 K with market capitalization of 74.46 K, debt of 630.94 K, and cash on hands of 2.33 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Orthometrix fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
74.46 K | 74.46 K | 630.94 K | 2.33 K |
Orthometrix Investor Information
The company had not issued any dividends in recent years. Orthometrix had 3:2 split on the 17th of June 1996. Based on the key measurements obtained from Orthometrix's financial statements, Orthometrix is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Orthometrix Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Orthometrix has an asset utilization ratio of 362.38 percent. This suggests that the Company is making $3.62 for each dollar of assets. An increasing asset utilization means that Orthometrix is more efficient with each dollar of assets it utilizes for everyday operations.Orthometrix Profitability Analysis
The company reported the previous year's revenue of 1.07 M. Net Income was 63.54 K with profit before overhead, payroll, taxes, and interest of 591.05 K.About Orthometrix Valuation
Our relative valuation model uses a comparative analysis of Orthometrix. We calculate exposure to Orthometrix's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Orthometrix's related companies.Orthometrix, Inc. develops technologies, procedures, and devices to help increase musculoskeletal mobility, as well as non-invasive technologies to treat the pain associated with osteoarthritis, plantar fasciitis, and other musculoskeletal conditions that reduce mobility. Orthometrix, Inc. was founded in 1993 and is headquartered in Naples, Florida. Orthometrix operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 7 people.
Additional Tools for Orthometrix Stock Analysis
When running Orthometrix's price analysis, check to measure Orthometrix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthometrix is operating at the current time. Most of Orthometrix's value examination focuses on studying past and present price action to predict the probability of Orthometrix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthometrix's price. Additionally, you may evaluate how the addition of Orthometrix to your portfolios can decrease your overall portfolio volatility.